Marissa RussoJournalist

Fierce Biotech and 1 other title

Health & social care coverage read by Vital Signs

2 articles

Across 1 topic, first on 30 Aug 2026, most recently 18 Sept 2026.

This counts only pieces our coverage scan read on the topics Vital Signs tracks, not their full output.

What they cover

Who they quote

Voices credited in their pieces. A reporter who has called someone before is likely to call them again.

Recent articles

  1. Rare EGFR mutation increases lung cancer risk 62 times in never smokers

    Fierce BiotechRespiratory (asthma/COPD)18 Sept 2026

  2. Zydus’ Sentynl pens $475M deal for Mereo’s phase 3-ready rare genetic lung disease drug

    FierceBiotechRespiratory (asthma/COPD)30 Aug 2026

Bylines and quoted sources are read automatically from UK coverage of the topics Vital Signs tracks, so this page reflects what our scan has read rather than a complete record. Where a biography and photograph appear, they are published by the outlet itself about its own correspondent, and linked above. Social accounts are not held: asserting an unverified one would attach a real person to an account that might not be theirs. See the methodology, or email contact@bridgeheadcommunications.com to correct anything on it.